Not all blood tests are created equal. While a comprehensive metabolic panel might include 30+ markers, research has identified a subset that are disproportionately powerful at predicting lifespan, healthspan, and disease risk. These are the biomarkers that longevity researchers, functional medicine practitioners, and platforms like SOVR Health prioritize — because they capture the biological processes most closely tied to aging.
Here are the ten biomarkers with the strongest evidence linking them to longevity outcomes, ranked by the breadth and quality of supporting research.
1. High-Sensitivity C-Reactive Protein (hs-CRP)
CRP is produced by the liver in response to inflammation. The high-sensitivity assay detects low-grade chronic inflammation — the "inflammaging" that drives atherosclerosis, neurodegeneration, and cancer. The JUPITER trial (17,802 participants) showed that individuals with elevated hs-CRP (>2 mg/L) but normal LDL cholesterol had a 44% reduction in cardiovascular events when treated with rosuvastatin [1]. Optimal range: below 1.0 mg/L. Above 3.0 mg/L signals high cardiovascular risk regardless of cholesterol levels.
2. Fasting Glucose and HbA1c
Fasting glucose provides a snapshot; HbA1c (glycated hemoglobin) provides a 90-day average. Together, they capture metabolic health — the single largest modifiable risk factor for aging. A meta-analysis of 97 prospective studies (820,900 participants) found that each 1 mmol/L increase in fasting glucose above 5.6 mmol/L (100 mg/dL) was associated with a 17% increase in all-cause mortality [2]. Optimal range: fasting glucose 70-90 mg/dL; HbA1c below 5.4%.
3. Apolipoprotein B (ApoB)
ApoB is the protein carried by every atherogenic lipoprotein particle (LDL, VLDL, Lp(a)). Unlike LDL-C (which measures cholesterol mass), ApoB counts the actual number of particles capable of penetrating the arterial wall. A Mendelian randomization study in the European Heart Journal demonstrated that ApoB is the primary causal agent in atherosclerosis — not LDL-C, not triglycerides [3]. Optimal range: below 80 mg/dL for average risk; below 60 mg/dL for high-risk individuals.
4. Vitamin D (25-Hydroxyvitamin D)
Vitamin D functions as a hormone affecting over 1,000 genes involved in immune function, bone metabolism, and inflammation. A meta-analysis in the BMJ (73 cohort studies, 849,412 participants) found that low vitamin D levels were associated with a 35% increase in cardiovascular mortality and a 14% increase in cancer mortality [4]. The Endocrine Society recommends levels above 30 ng/mL, but longevity-focused practitioners target 40-60 ng/mL. Optimal range: 40-60 ng/mL.
5. Red Blood Cell Distribution Width (RDW)
RDW measures the variation in red blood cell size. It is one of the most underappreciated mortality predictors in medicine. A study of 25,455 adults found that elevated RDW (>14.5%) was associated with a 71% increase in all-cause mortality over 12 years, independent of anemia, inflammation, and nutritional status [5]. It likely reflects bone marrow stress, chronic inflammation, or micronutrient deficiency. Optimal range: 11.5-13.5%.
6. Estimated Glomerular Filtration Rate (eGFR)
eGFR estimates how efficiently your kidneys filter waste from the blood. Kidney function declines approximately 1 mL/min/1.73m² per year after age 30, but the rate varies enormously based on blood pressure, glucose control, hydration, and medication use. A meta-analysis of 46 cohorts (2.05 million participants) found that eGFR below 60 was associated with a 73% increase in all-cause mortality [6]. Optimal range: above 90 mL/min/1.73m².
7. Albumin
Serum albumin reflects liver synthetic function, nutritional status, and systemic inflammation. It is one of the nine PhenoAge biomarkers and one of the strongest predictors of mortality in hospitalized and community-dwelling adults. A meta-analysis found that each 1 g/dL decrease in albumin was associated with a 137% increase in mortality risk [7]. Optimal range: 4.2-5.0 g/dL.
8. Homocysteine
Homocysteine is an amino acid intermediate in the methionine cycle. Elevated levels (>12 µmol/L) are associated with cardiovascular disease, cognitive decline, and osteoporotic fractures. A meta-analysis of 30 prospective studies found that each 5 µmol/L increase in homocysteine was associated with a 27% increase in coronary heart disease risk [8]. Homocysteine is modifiable through B-vitamin supplementation (B6, B12, folate). Optimal range: 6-9 µmol/L.
9. DHEA-Sulfate (DHEA-S)
DHEA-S is the most abundant steroid hormone in the human body and declines approximately 2-3% per year after age 25. Low DHEA-S is associated with increased cardiovascular mortality, reduced immune function, and accelerated cognitive decline. The Baltimore Longitudinal Study of Aging found that higher DHEA-S levels were associated with greater longevity in men [9]. Optimal range: age-dependent, but generally 200-400 µg/dL for adults over 40.
10. Omega-3 Index
The Omega-3 Index measures the percentage of EPA and DHA in red blood cell membranes. A study of 2,500 Framingham Heart Study participants found that individuals in the highest Omega-3 Index quintile (>6.8%) lived an average of 4.7 years longer than those in the lowest quintile (<4.2%) [10]. The REDUCE-IT trial (8,179 participants) showed that high-dose EPA reduced cardiovascular events by 25% [11]. Optimal range: 8-12%.
Beyond Individual Markers: The Power of Composite Scores
While each biomarker provides valuable information individually, their predictive power increases dramatically when combined into composite scores like PhenoAge. This is because aging is a multi-system process — no single marker captures the full picture. SOVR Health analyzes over 100 biomarkers and uses the PhenoAge algorithm as the integrative framework, then drills down into individual markers to identify specific intervention targets.
The key insight from longevity research is that these biomarkers are not just diagnostic — they are modifiable. Every marker on this list can be improved through evidence-based interventions, from dietary changes and exercise to targeted supplementation and, when appropriate, prescription medications. The first step is measurement.
References
- [1]Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195-2207.
- [2]Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease. Lancet. 2010;375(9733):2215-2222.
- [3]Ference BA, Kastelein JJP, Ray KK, et al. Association of triglyceride-lowering LPL variants and LDL-C-lowering LDLR variants with risk of coronary heart disease. JAMA. 2019;321(4):364-373.
- [4]Chowdhury R, Kunutsor S, Vitezova A, et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis. BMJ. 2014;348:g1903.
- [5]Patel KV, Ferrucci L, Ershler WB, Longo DL, Guralnik JM. Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med. 2009;169(5):515-523.
- [6]Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality. Lancet. 2010;375(9731):2073-2081.
- [7]Goldwasser P, Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol. 1997;50(6):693-703.
- [8]Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002;288(16):2015-2022.
- [9]Enomoto M, Adachi H, Fukami A, et al. Serum dehydroepiandrosterone sulfate levels predict longevity in men. J Am Geriatr Soc. 2008;56(6):994-998.
- [10]Harris WS, Tintle NL, Imamura F, et al. Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies. Nat Commun. 2021;12:2329.
- [11]Bhatt DL, Steg PG, Miller M, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med. 2019;380(1):11-22.